Modular Medical Appoints Industry Veteran Jeff Goldberg to Board of Directors
Modular Medical (NASDAQ:MODD) has appointed Jeff Goldberg to its Board of Directors. Goldberg brings extensive experience in healthcare, life sciences, and medical device leadership, particularly in generic insulin development. He currently serves as Chairman of Lannett Company and has a notable background working with MiniMed founder Alfred E. Mann. As President and CEO at IncuMed, Mann's incubator, Goldberg oversaw drug-device combination products, including an insulin patch-pump program.
Goldberg's appointment aligns with Modular Medical's focus on developing user-friendly and affordable insulin delivery technology, as the company has already received FDA clearance for its patch pump designed for "almost-pumpers". His experience in regulatory strategy, operations turnaround, and successful exits positions him well to contribute to Modular Medical's mission of simplifying diabetes care worldwide.
Modular Medical (NASDAQ:MODD) ha nominato Jeff Goldberg nel suo Consiglio di Amministrazione. Goldberg porta con sé una vasta esperienza nel settore sanitario, nelle scienze della vita e nella leadership di dispositivi medici, con particolare attenzione allo sviluppo di insulina generica. Attualmente è Presidente di Lannett Company e ha un importante background collaborando con Alfred E. Mann, fondatore di MiniMed. Come Presidente e CEO di IncuMed, l'incubatore di Mann, Goldberg ha supervisionato prodotti combinati farmaco-dispositivo, incluso un programma per un cerotto-pompa di insulina.
La nomina di Goldberg è in linea con l'obiettivo di Modular Medical di sviluppare tecnologie di somministrazione dell'insulina facili da usare e accessibili, dato che l'azienda ha già ottenuto l'approvazione FDA per la sua pompa a cerotto pensata per gli "almost-pumpers". La sua esperienza in strategie regolatorie, rilancio operativo e uscite di successo lo rende un elemento chiave per contribuire alla missione di Modular Medical di semplificare la cura del diabete a livello globale.
Modular Medical (NASDAQ:MODD) ha nombrado a Jeff Goldberg en su Junta Directiva. Goldberg aporta una amplia experiencia en el sector sanitario, ciencias de la vida y liderazgo en dispositivos médicos, especialmente en el desarrollo de insulina genérica. Actualmente es Presidente de Lannett Company y tiene un destacado historial trabajando con Alfred E. Mann, fundador de MiniMed. Como Presidente y CEO de IncuMed, la incubadora de Mann, Goldberg supervisó productos combinados de fármaco y dispositivo, incluyendo un programa de parche-bomba de insulina.
El nombramiento de Goldberg se alinea con el enfoque de Modular Medical en desarrollar tecnología de administración de insulina accesible y fácil de usar, ya que la empresa ha recibido la aprobación de la FDA para su bomba parche diseñada para los "almost-pumpers". Su experiencia en estrategia regulatoria, reestructuración operativa y salidas exitosas lo posiciona para contribuir a la misión de Modular Medical de simplificar el cuidado de la diabetes a nivel mundial.
Modular Medical (NASDAQ:MODD)는 Jeff Goldberg를 이사회에 임명했습니다. Goldberg는 의료, 생명과학 및 의료기기 분야에서 특히 제네릭 인슐린 개발에 대한 풍부한 경험을 보유하고 있습니다. 그는 현재 Lannett Company의 회장으로 재직 중이며, MiniMed 창립자인 Alfred E. Mann과의 협력 경력이 돋보입니다. Mann의 인큐베이터인 IncuMed의 사장 겸 CEO로서 Goldberg는 인슐린 패치 펌프 프로그램을 포함한 약물-기기 결합 제품을 총괄했습니다.
Goldberg의 임명은 Modular Medical이 사용자 친화적이고 저렴한 인슐린 전달 기술 개발에 집중하는 전략과 맞닿아 있습니다. 이 회사는 이미 "almost-pumpers"를 위한 패치 펌프에 대해 FDA 승인을 받았습니다. 규제 전략, 운영 개선 및 성공적인 매각 경험을 가진 Goldberg는 전 세계 당뇨병 치료를 단순화하려는 Modular Medical의 사명에 크게 기여할 것입니다.
Modular Medical (NASDAQ:MODD) a nommé Jeff Goldberg à son conseil d'administration. Goldberg apporte une vaste expérience dans le domaine de la santé, des sciences de la vie et du leadership dans les dispositifs médicaux, notamment dans le développement d'insuline générique. Il est actuellement président de Lannett Company et possède un parcours notable avec Alfred E. Mann, fondateur de MiniMed. En tant que président et CEO d'IncuMed, l'incubateur de Mann, Goldberg a supervisé des produits combinant médicaments et dispositifs, y compris un programme de patch-pompe à insuline.
La nomination de Goldberg s'inscrit dans l'orientation de Modular Medical visant à développer une technologie de délivrance d'insuline simple d'utilisation et abordable, l'entreprise ayant déjà obtenu l'approbation de la FDA pour sa pompe patch destinée aux "almost-pumpers". Son expérience en stratégie réglementaire, redressement opérationnel et sorties réussies le positionne idéalement pour contribuer à la mission de Modular Medical de simplifier la prise en charge du diabète à l'échelle mondiale.
Modular Medical (NASDAQ:MODD) hat Jeff Goldberg in seinen Vorstand berufen. Goldberg bringt umfassende Erfahrung im Gesundheitswesen, in den Lebenswissenschaften und in der Führung von Medizinprodukten mit, insbesondere in der Entwicklung von generischer Insulin. Derzeit ist er Vorsitzender der Lannett Company und verfügt über eine bemerkenswerte Vergangenheit in der Zusammenarbeit mit Alfred E. Mann, dem Gründer von MiniMed. Als Präsident und CEO von IncuMed, Manns Inkubator, leitete Goldberg Arzneimittel-Geräte-Kombinationsprodukte, darunter ein Insulin-Patch-Pumpen-Programm.
Goldbergs Ernennung passt zu Modular Medicals Fokus auf die Entwicklung benutzerfreundlicher und erschwinglicher Insulinabgabetechnologien, da das Unternehmen bereits die FDA-Zulassung für seine Patch-Pumpe erhalten hat, die für "fast-Pumpen" konzipiert ist. Seine Erfahrung in regulatorischer Strategie, operativer Umstrukturierung und erfolgreichen Exits qualifiziert ihn hervorragend, Modular Medicals Mission zur Vereinfachung der Diabetesversorgung weltweit zu unterstützen.
- Addition of experienced board member with specific expertise in insulin delivery technology and drug-device combinations
- New director brings successful track record in regulatory strategy and operations turnaround
- Strategic alignment with company's focus on affordable insulin delivery solutions
- None.
SAN DIEGO, CA / ACCESS Newswire / May 28, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to meet the needs of "almost-pumpers" with its user-friendly and affordable design, today announced the appointment of Jeff Goldberg to its Board of Directors. Mr. Goldberg brings decades of experience in health care, life sciences, and medical device leadership, including development of generic insulin. Mr. Goldberg began his work in medical technology alongside pioneering medical entrepreneur, and founder of MiniMed, Alfred E. Mann.
"We are pleased to welcome Jeff Goldberg to the Modular Medical board," said Jeb Besser, CEO of Modular Medical. "Jeff's unique background at the intersection of affordable drug-device combinations will be instrumental, as we advance our mission to simplify insulin delivery and improve diabetes care worldwide."
Mr. Goldberg currently serves as Chairman of Lannett Company, Inc., a generic pharmaceutical manufacturer where he has helped execute a post-restructuring turnaround. During his tenure, Lannett has made significant strides in launching a generic insulin product - progress that aligns closely with Modular Medical's commitment to innovation and affordability in diabetes care.
In addition to his work at Lannett, Mr. Goldberg previously served as President and CEO within Alfred E. Mann's incubator, IncuMed, where he oversaw multiple portfolio companies focused on drug-device combination products, including an insulin patch-pump program. His tenure with Mr. Mann's enterprises included pivotal roles in regulatory strategy, operations turnaround, and successful exits, underscoring his ability to guide early-stage technologies to commercial viability.
"Modular Medical is advancing a truly disruptive approach to insulin delivery," said Mr. Goldberg. "I'm excited to join the board and contribute to the Company's journey toward simplifying treatment for people living with diabetes, particularly as the industry shifts toward more accessible and patient-friendly solutions."
Mr. Goldberg also serves on the boards of several health-care and consumer-focused companies, including ATI Physical Therapy, Cano Health, and Eating Recovery Centers. He holds a JD from UCLA School of Law and an AB from Harvard College.
About Modular Medical
Modular Medical, Inc. (Nasdaq:MODD) is a development-stage medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the Company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. Its mission is to improve access to the highest standard of glycemic control for people with diabetes taking it beyond "superusers" and providing "diabetes care for the rest of us."
Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding Modular Medical, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its insulin pump. More information is available at https://modular-medical.com.
CONTACT:
Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
+1 (617) 399-1741
IR@modular-medical.com
SOURCE: Modular Medical, Inc.
View the original press release on ACCESS Newswire
FAQ
Who is Jeff Goldberg and why did Modular Medical (MODD) appoint him to their board?
What is Modular Medical's (MODD) main product focus?
What is Jeff Goldberg's current role outside of Modular Medical (MODD)?
What experience does Jeff Goldberg bring to Modular Medical's (MODD) board?
